PSM Board Members Speak at 7th Annual San Diego Health Policy Conference, “Public-Private Partnerships in Global Health”

March 28, 2011

The reality that key issues in healthcare go beyond geo-
political lines is evident by challenges associated with important public
health concerns. Pandemics, human-sourced disasters, drug safety, HIV-
AIDS and TB control and treatment all represent global circumstances
that require a wide array of stakeholder efforts to effectively address.

Simultaneously, a much broader range of global health organizations have
increasingly played a role in addressing these and other international
public health needs beyond traditional public health authorities.
Foundations, international agencies outside the health realm, and the
private sector have also become key participants in creating policies and
programs in an effort to promote global public health.

Hence, the Institute of Health Law Studies (IHLS) convened the 7th Annual
San Diego Health Policy Conference
, entitled “Public-Private Partnerships
in Global Health.” The conference explored different models of public-
private partnerships emerging from the expansion of global health activities
to these larger bodies of groups, and will provide lessons for participants,
providers, and policymakers as to how to best engage these entities and
systems to most effectively and efficiently advance global health.

Read More

PSM Board Members Speak at 7th Annual San Diego Health Policy Conference, “Public-Private Partnerships in Global Health”

March 28, 2011

The reality that key issues in healthcare go beyond geo-
political lines is evident by challenges associated with important public
health concerns. Pandemics, human-sourced disasters, drug safety, HIV-
AIDS and TB control and treatment all represent global circumstances
that require a wide array of stakeholder efforts to effectively address.

Simultaneously, a much broader range of global health organizations have
increasingly played a role in addressing these and other international
public health needs beyond traditional public health authorities.
Foundations, international agencies outside the health realm, and the
private sector have also become key participants in creating policies and
programs in an effort to promote global public health.

Hence, the Institute of Health Law Studies (IHLS) convened the 7th Annual
San Diego Health Policy Conference
, entitled “Public-Private Partnerships
in Global Health.” The conference explored different models of public-
private partnerships emerging from the expansion of global health activities
to these larger bodies of groups, and will provide lessons for participants,
providers, and policymakers as to how to best engage these entities and
systems to most effectively and efficiently advance global health.

Read More

PSM Board Members Speak at 7th Annual San Diego Health Policy Conference, “Public-Private Partnerships in Global Health”

March 28, 2011

Tom Kubic speaking at another conferenceby Safe Medicines via Flickr. The reality that key issues in healthcare go beyond geo- political lines is evident by challenges associated with important public health concerns. Pandemics, human-sourced disasters, drug safety, HIV- AIDS and TB control and treatment all represent global circumstances that require a wide array of stakeholder…

Read More

15 South Korean Pharmacists Indicted for Selling Fake Drugs

March 28, 2011

Investigators at the Seoul Central District Prosecutors Office have filed indictments against fifteen Seoul pharmacists for selling fake erectile dysfunction medications manufactured in China. Reports the Korea Herald, this is the first time pharmacists have been charged with selling fake medication in Seoul. Prosecutors say the pharmacists bought the medication from smugglers and then sold…

Read More

South America and Africa Employ Anti-Counterfeiting Technologies to Save Lives

March 25, 2011

Responding to the ongoing cases of counterfeiters in their countries, Argentinian and Nigerian pharmaceutical manufacturers are installing anti-counterfeiting solutions in their products. Gador Laboratories, located in Buenos Aires, is deploying a radio frequency identification (RFID) solution to track products and pallets, after a month-long pilot. The system has three levels of security with item-level RFID…

Read More

Protective Services for Senior Citizens Focus on Counterfeit Drug Scams

March 25, 2011

Instances of elderly exploitation are rising and protective services in Pike County are taking a lead in educating senior citizens to avoid counterfeit drug scams. Providing services for senior citizens over the age of 60, Robin LoDolce, the Executive Director for the Pike aging office, is concerned about the recent trends in exploitation, reports the…

Read More

Ireland’s On a Dangerous Diet of Illegal Online Pharmacies

March 25, 2011

The Irish medicines Board (IMB) detained almost double the quantity of counterfeit and illegal medicines in 2010 as it did in 2009 with a 500% increase in the quantity of illegal weight loss products many of which contained the dangerous drug sibutramine which can cause heart attack and stroke. IMB said there was a 66%…

Read More

Prescription Drug Safety Hill Briefing: Wednesday, March 30, 2011 at Noon

March 24, 2011

Tom Kubic at the Congressional briefing on March 30, 2011.  See all the photos. Counterfeit drugs – like the 20,000 pills seized last month by U.S. Customs official at Kennedy Airport in New York – defraud consumers and deny patients therapies that can alleviate suffering and save lives. Unfortunately, in some cases, these drugs have caused great…

Read More

Carcinogenic Pill Hawker Sentenced to Three Months

March 23, 2011

Philadelphia resident Mimi Trieu, 46, was sentenced on March 10th to three months in prison for importing and distributing four million fake diet pills that contained a carcinogenic chemical solvent among other dangerous ingredients. The U.S. Department of Justice announced her sentencing was a result of her guilty plea to an 18 count indictment including…

Read More

Watch Out for Fake Radiation Preventatives Warns FDA

March 22, 2011

Due to public concern related to the nuclear incident in Japan, the FDA is warning consumers to be wary of drugs falsely touting radiation exposure treatment.

Potassium iodide (KI) has been approved by the FDA to prevent thyroid cancer in people internally contaminated with radioactive iodine, however the U.S. government is not recommending that residents take KI, even as a preventative. The Nuclear Regulatory Commission indicates that no part of the U.S. is expected to experience any harmful levels of radioactivity.

The FDA is warning consumers to be wary of internet sites and retail outlets promoting products that make claims to prevent or treat radiation, these claims may be false and the products may not be FDA approved.

Read More